Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Cleemput

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Pharmacoeconomics|December 22, 2017
Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment GuidelinesSalah Ghabri, Irina Cleemput, Jean-Michel Josselin
International Journal of Technology Assessment in Health Care|September 21, 2006
Balancing evidence and public opinion in health technology assessments: the case of leukoreductionIrina Cleemput, Mark Leys, Dirk Ramaekers, et al.
Health Policy (Amsterdam, Netherlands)|October 11, 2014
The impact of no-fault compensation on health care expenditures: an empirical study of OECD countriesTom Vandersteegen, Wim Marneffe, Irina Cleemput, et al.
Health Policy (Amsterdam, Netherlands)|July 10, 2018
A multi-criteria decision approach for ranking unmet needs in healthcareIrina Cleemput, Stephan Devriese, Laurence Kohn, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|August 24, 2013
Infection prevention and control strategies in the era of limited resources and quality improvement: a perspective paperDominique Vandijck, Irina Cleemput, Johan Hellings, et al.
Pharmacoeconomics - Open|August 4, 2022
An EQ-5D-5L Value Set for BelgiumNicolas Bouckaert, Irina Cleemput, Stephan Devriese, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2011
Stimulating pharmaceutical innovation in the EULieven Annemans, Irina Cleemput, Frank Hulstaert, et al.
Frontiers in Pharmacology|October 21, 2011
Valorising and creating access to innovative medicines in the European unionLieven Annemans, Irina Cleemput, Frank Hulstaert, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EULieven Annemans, Irina Cleemput, Frank Hulstaert, et al.
International Journal of Technology Assessment in Health Care|September 18, 2012
European drug reimbursement systems' legitimacy: five-country comparison and policy toolIrina Cleemput, Margreet Franken, Marc Koopmanschap, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Pharmacoeconomics|December 22, 2017
Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment GuidelinesSalah Ghabri, Irina Cleemput, Jean-Michel Josselin
International Journal of Technology Assessment in Health Care|September 21, 2006
Balancing evidence and public opinion in health technology assessments: the case of leukoreductionIrina Cleemput, Mark Leys, Dirk Ramaekers, et al.
Health Policy (Amsterdam, Netherlands)|October 11, 2014
The impact of no-fault compensation on health care expenditures: an empirical study of OECD countriesTom Vandersteegen, Wim Marneffe, Irina Cleemput, et al.
Health Policy (Amsterdam, Netherlands)|July 10, 2018
A multi-criteria decision approach for ranking unmet needs in healthcareIrina Cleemput, Stephan Devriese, Laurence Kohn, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|August 24, 2013
Infection prevention and control strategies in the era of limited resources and quality improvement: a perspective paperDominique Vandijck, Irina Cleemput, Johan Hellings, et al.
Pharmacoeconomics - Open|August 4, 2022
An EQ-5D-5L Value Set for BelgiumNicolas Bouckaert, Irina Cleemput, Stephan Devriese, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 16, 2011
Stimulating pharmaceutical innovation in the EULieven Annemans, Irina Cleemput, Frank Hulstaert, et al.
Frontiers in Pharmacology|October 21, 2011
Valorising and creating access to innovative medicines in the European unionLieven Annemans, Irina Cleemput, Frank Hulstaert, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EULieven Annemans, Irina Cleemput, Frank Hulstaert, et al.
International Journal of Technology Assessment in Health Care|September 18, 2012
European drug reimbursement systems' legitimacy: five-country comparison and policy toolIrina Cleemput, Margreet Franken, Marc Koopmanschap, et al.
Pageof 8